anmelden
QIX Deutschland
16.839,15
PKT
-370,39
PKT
-2,15
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu QIX Deutschland-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 18.12.25 | Siemens Healthineers Overweight | Barclays Capital | |
| 18.12.25 | Brenntag Buy | Warburg Research | |
| 18.12.25 | RATIONAL Buy | UBS AG | |
| 18.12.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 17.12.25 | Henkel vz. Market-Perform | Bernstein Research | |
| 17.12.25 | Hannover Rück Buy | UBS AG | |
| 17.12.25 | Sartorius vz. Buy | Deutsche Bank AG | |
| 17.12.25 | Carl Zeiss Meditec Buy | Goldman Sachs Group Inc. | |
| 17.12.25 | Nemetschek Hold | Deutsche Bank AG | |
| 17.12.25 | Siemens Healthineers Outperform | RBC Capital Markets | |
| 16.12.25 | Sartorius vz. Outperform | Bernstein Research | |
| 16.12.25 | Carl Zeiss Meditec Outperform | Bernstein Research | |
| 16.12.25 | Gerresheimer Underperform | Bernstein Research | |
| 16.12.25 | Siemens Healthineers Outperform | Bernstein Research | |
| 16.12.25 | Symrise Equal Weight | Barclays Capital | |
| 16.12.25 | Carl Zeiss Meditec Halten | DZ BANK | |
| 16.12.25 | Evonik Neutral | UBS AG | |
| 16.12.25 | adidas Outperform | Bernstein Research | |
| 15.12.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 15.12.25 | Carl Zeiss Meditec Hold | Deutsche Bank AG | |
| 15.12.25 | Carl Zeiss Meditec Underweight | JP Morgan Chase & Co. | |
| 15.12.25 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 15.12.25 | Symrise Overweight | JP Morgan Chase & Co. | |
| 12.12.25 | Carl Zeiss Meditec Hold | Deutsche Bank AG | |
| 12.12.25 | Carl Zeiss Meditec Neutral | UBS AG | |
| 12.12.25 | Brenntag Hold | Deutsche Bank AG | |
| 12.12.25 | SAP Buy | Goldman Sachs Group Inc. | |
| 12.12.25 | Carl Zeiss Meditec Outperform | Bernstein Research | |
| 11.12.25 | Deutsche Börse Kaufen | DZ BANK | |
| 11.12.25 | Carl Zeiss Meditec Overweight | Barclays Capital | |
| 11.12.25 | Deutsche Börse Overweight | Barclays Capital | |
| 11.12.25 | Carl Zeiss Meditec Buy | Goldman Sachs Group Inc. | |
| 11.12.25 | Carl Zeiss Meditec Sector Perform | RBC Capital Markets | |
| 11.12.25 | Carl Zeiss Meditec Outperform | Bernstein Research | |
| 11.12.25 | Carl Zeiss Meditec Underweight | JP Morgan Chase & Co. | |
| 11.12.25 | Deutsche Börse Sector Perform | RBC Capital Markets | |
| 11.12.25 | Deutsche Börse Overweight | JP Morgan Chase & Co. | |
| 10.12.25 | Deutsche Börse Overweight | Barclays Capital | |
| 10.12.25 | Brenntag Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10.12.25 | Carl Zeiss Meditec Hold | Deutsche Bank AG |